Niraparib tosylate monohydrate chemical name
WebbNiraparib hydrochloride; Niraparib tosylate monohydrate; Niraparib; Brand Names: Zejula: Indication: Niraparib is indicated for the maintenance treatment of adult patients with advanced or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to first-line platinum-based ... WebbNiraparib is an orally active small molecule PARP inhibitor developed by Tesaro to treat ovarian cancer.It is used for the maintenance treatment of adult patients with recurrent …
Niraparib tosylate monohydrate chemical name
Did you know?
Webb25 feb. 2024 · Niraparib (Monograph) Brand name: Zejula Drug class: Antineoplastic Agents - PARP Inhibitors - Poly(ADP-ribose) Polymerase Inhibitors VA class: AN900 … WebbNiraparib is in a class of medications called poly (ADP-ribose) polymerase (PARP) inhibitors. It works by killing cancer cells. How should this medicine be used? Niraparib comes as a capsule to take by mouth once daily. Take niraparib at around the same time every day with or without food.
Webb20 okt. 2016 · Niraparib is a poly-ADP ribose polymerase inhibitor used to treat recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer responding to platinum … Webb12 jan. 2024 · Niraparib (MK-4827) tosylate hydrate is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with IC50s of 3.8 and 2.1 nM, respectively. Niraparib tosylate hydrate leads to inhibition of repair of DNA damage, activates apoptosis and shows anti-tumor activity [1] [2] [3]. Properties Spectrum Names
Webb16 mars 2024 · Radiolabelled niraparib was manufactured, packed and labelled by Quotient Clinical (Ruddington, Nottingham, UK). 14 C–Niraparib capsules for oral … WebbNIRAPARIB TOSYLATE MONOHYDRATE Molecular Formula CHNOS Average mass 510.605 Da Monoisotopic mass 510.193695 Da ChemSpider ID 52083979 - 1 of 1 defined stereocentres More details: Names Properties Searches Spectra Vendors Articles More Names and Synonyms Database ID (s) Validated by Experts, Validated by Users, Non …
Webb1613220-15-7. Niraparib (MK-4827) tosylate hydrate is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with IC50s of 3.8 and 2.1 nM, respectively. Niraparib tosylate hydrate leads to inhibition of repair of DNA damage, activates apoptosis and shows anti-tumor activity [1] [2] [3]. Niraparib (MK-4827) inhibits PARP …
WebbScottish Medicines Consortium (SMC) decisions For niraparib. SMC No. 1341/18. Niraparib tosylate monohydrate (Zejula®) as monotherapy for the maintenance treatment of adult patients with platinum-sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or … jim ashby thalhimerWebbA paediatric investigation plan for niraparib (tosylate monohydrate) (Zejula), film coated tablet, capsule, hard, age appropriate oral liquid formulation, oral use, the details of which are set out in the opinion of the Paediatric Committee of the European Medicines Agency annexed hereto, together with its appendices, is hereby agreed. Article 2 jim asbell \\u0026 the tropiholicsWebbProduct name: Niraparib Tosylate Product Catalogue Number: 206609 Brand: MedKoo Biosciences CAS-No: 1038915-73-9 (tosylate) 1.2 Relevant identified uses of the … jim ashby nova healthWebb12 apr. 2024 · The FDA approved niraparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, on March 27, 2024, for maintenance treatment of patients with recurrent epithelial ovarian, fallopian tube, or primary... installing windows 7 in vmware workstationWebbChemical name: Niraparib: CAS Number: 1038915-60-4: Category: aromatics,heterocycles,pharmaceutical standards,intermediates,fine chemicals: … installing windows 7 on flash driveWebbNiraparib tosylate C26H28N4O4S - PubChem Apologies, we are having some trouble retrieving data from our servers... PUGVIEW FETCH ERROR: 403 Forbidden National Center for Biotechnology Information 8600 Rockville Pike, Bethesda, MD, 20894 USA Contact Policies FOIA HHS Vulnerability Disclosure National Library of Medicine jim asfoor trail la crosse wiWebb21 juni 2024 · Key facts Decision P/0244/2024: EMA decision of 15 July 2024 on the granting of a product specific waiver for niraparib (tosylate monohydrate) / … jim ashley forvis